NCT00282243View on ClinicalTrials.gov

A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Liver Transplant Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Liver Transplantation
Interventions
DRUG

tacrolimus modified release (MR)

Oral

DRUG

tacrolimus

Oral

Trial Locations (10)

10029

New York

21287

Baltimore

45267

Cincinnati

48109

Ann Arbor

53792

Madison

55455

Minneapolis

55905

Rochester

75246

Dallas

80262

Denver

Unknown

Palo Alto

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY